InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Mineralys Therapeutics, Inc.

MLYS Clue Score35
United States Fiscal year ends December CIK 0001933414 Results filed 4 Nov 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

42
Insider
Date
Role
Action
Shares
Price
Amount
Jon Congleton
30 Sep 2026
Chief Executive Officer
Sold on a plan
75,000
$25.46
$1.91M
David Malcom Rodman
15 Jul 2026
Chief Medical Officer
Sold on a plan
6,349
$26.61
$168.95K
Jon Congleton
13 Jul 2026
Chief Executive Officer
Sold on a plan
10,700
$27.24
$291.44K
Jon Congleton
30 Jun 2026
Chief Executive Officer
Sold on a plan
17,000
$26.82
$455.90K
Jon Congleton
30 Jun 2026
Chief Executive Officer
Sold on a plan
58,000
$25.94
$1.50M
David Malcom Rodman
15 Apr 2026
Chief Medical Officer
Sold on a plan
6,348
$27.66
$175.59K
Jon Congleton
13 Apr 2026
Chief Executive Officer
Sold on a plan
15,730
$26.83
$421.98K
Jon Congleton
31 Mar 2026
Chief Executive Officer
Sold on a plan
453
$27.05
$12.25K
Jon Congleton
31 Mar 2026
Chief Executive Officer
Sold on a plan
55,183
$26.54
$1.46M
Jon Congleton
31 Mar 2026
Chief Executive Officer
Sold on a plan
19,364
$25.50
$493.79K
David Malcom Rodman
14 Jan 2026
Chief Medical Officer
Sold on a plan
11,367
$32.61
$370.64K
Adam Scott Levy
12 Jan 2026
CFO and Secretary
Sold on a plan
10,758
$32.14
$345.72K
Jon Congleton
12 Jan 2026
Chief Executive Officer
Sold on a plan
7,117
$33.15
$235.93K
Jon Congleton
12 Jan 2026
Chief Executive Officer
Sold on a plan
9,119
$32.21
$293.71K
David Malcom Rodman
15 Oct 2025
Chief Medical Officer
Sold on a plan
10,369
$43.01
$445.98K
Jon Congleton
13 Oct 2025
Chief Executive Officer
Sold on a plan
1,552
$43.03
$66.78K
Jon Congleton
13 Oct 2025
Chief Executive Officer
Sold on a plan
13,548
$42.63
$577.54K
Adam Scott Levy
13 Oct 2025
CFO and Secretary
Sold on a plan
3,392
$42.26
$143.33K
Adam Scott Levy
13 Oct 2025
CFO and Secretary
Sold on a plan
7,366
$41.90
$308.65K
David Malcom Rodman
15 Sep 2025
Chief Medical Officer
Sold on a plan
2,065
$36.47
$75.32K
David Malcom Rodman
15 Sep 2025
Chief Medical Officer
Sold on a plan
9,302
$35.90
$333.95K
David Malcom Rodman
13 Aug 2025
Chief Medical Officer
Sold on a plan
11,365
$12.93
$146.99K
Adam Scott Levy
11 Jul 2025
CFO and Secretary
Sold on a plan
10,758
$14.45
$155.45K
Jon Congleton
11 Jul 2025
Chief Executive Officer
Sold on a plan
15,884
$14.51
$230.43K
David Malcom Rodman
13 Jun 2025
Chief Medical Officer
Sold on a plan
11,366
$14.60
$165.93K
David Malcom Rodman
14 May 2025
Chief Medical Officer
Sold on a plan
11,366
$15.29
$173.77K
Jon Congleton
11 Apr 2025
Chief Executive Officer
Sold on a plan
15,319
$12.19
$186.80K
Adam Scott Levy
11 Apr 2025
CFO and Secretary
Sold on a plan
10,757
$12.06
$129.68K
Jon Congleton
13 Jan 2025
Chief Executive Officer
Sold on a plan
18,333
$9.06
$166.08K
Adam Scott Levy
13 Jan 2025
CFO and Secretary
Sold on a plan
100
$9.63
$963.00
Adam Scott Levy
13 Jan 2025
CFO and Secretary
Sold on a plan
10,657
$9.09
$96.90K
Jon Congleton
11 Oct 2024
Chief Executive Officer
Sold on a plan
15,271
$13.52
$206.43K
Adam Scott Levy
11 Oct 2024
CFO and Secretary
Sold on a plan
10,757
$13.57
$146.00K
Jon Congleton
11 Jul 2024
Chief Executive Officer
Sold on a plan
15,746
$13.34
$210.08K
Adam Scott Levy
11 Jul 2024
CFO and Secretary
Sold on a plan
10,757
$13.14
$141.39K
Jon Congleton
20 Jun 2024
Chief Executive Officer
Sold on a plan
14,940
$11.73
$175.24K
Jon Congleton
18 Jun 2024
Chief Executive Officer
Sold on a plan
16,607
$11.99
$199.07K
Jon Congleton
17 Jun 2024
Chief Executive Officer
Sold on a plan
17,766
$12.25
$217.71K
Jon Congleton
14 Jun 2024
Chief Executive Officer
Sold on a plan
16,229
$12.52
$203.16K
Jon Congleton
13 Jun 2024
Chief Executive Officer
Sold on a plan
39,961
$12.74
$509.03K
Jon Congleton
12 Jun 2024
Chief Executive Officer
Sold on a plan
16,607
$12.77
$212.01K
Adam Scott Levy
11 Jun 2024
CFO and Secretary
Sold on a plan
96,815
$12.94
$1.25M
Show all 177 transactions →

What was left out

Form 4 filings counted 162
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 24
Sales on a Rule 10b5-1 plan 42
Sales straight out of an exercise 71
Sales at will 13
Transactions with no price 0
Shares from compensation/vesting 16,509,572
History held since 13 Feb 2023